Psychemedics Stock Price, News & Analysis (NASDAQ:PMD)

$21.14 -0.25 (-1.17 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$21.14
Today's Range$20.88 - $21.49
52-Week Range$15.99 - $27.99
Volume4,130 shs
Average Volume12,692 shs
Market Capitalization$114.75 million
P/E Ratio19.05
Dividend Yield2.84%
Beta0.81

About Psychemedics (NASDAQ:PMD)

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical & Diagnostic Laboratories
Sub-IndustryN/A
SectorMedical & Diagnostic Laboratories
SymbolNASDAQ:PMD
CUSIPN/A
Phone+1-800-6288073

Debt

Debt-to-Equity Ratio0.05%
Current Ratio2.72%
Quick Ratio2.72%

Price-To-Earnings

Trailing P/E Ratio19.045045045045
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$38.98 million
Price / Sales2.98
Cash Flow$1.62 per share
Price / Cash13.02
Book Value$2.86 per share
Price / Book7.39

Profitability

Trailing EPS$1.11
Net Income$6.67 million
Net Margins15.06%
Return on Equity37.33%
Return on Assets24.58%

Miscellaneous

Employees206
Outstanding Shares5,490,000

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Wednesday, October 25th. Investors of record on Monday, November 6th will be given a dividend of $0.15 per share on Friday, November 17th. This represents a $0.60 annualized dividend and a dividend yield of 2.84%. The ex-dividend date of this dividend is Friday, November 3rd. View Psychemedics' Dividend History.

How were Psychemedics' earnings last quarter?

Psychemedics Corp. (NASDAQ:PMD) posted its quarterly earnings results on Tuesday, October, 24th. The company reported $0.25 earnings per share (EPS) for the quarter. The firm earned $10.05 million during the quarter. Psychemedics had a net margin of 15.06% and a return on equity of 37.33%. View Psychemedics' Earnings History.

When will Psychemedics make its next earnings announcement?

Psychemedics is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Psychemedics.

Who are some of Psychemedics' key competitors?

Who are Psychemedics' key executives?

Psychemedics' management team includes the folowing people:

  • Raymond C. Kubacki Jr., Chairman of the Board, President, Chief Executive Officer (Age 71)
  • Neil L. Lerner, Vice President - Finance (Age 48)
  • Michael I. Schaffer Ph.D., Vice President - Laboratory Operations (Age 71)
  • A. Clinton Allen, Independent Director (Age 73)
  • Harry F. Connick Sr., Independent Director (Age 90)
  • Walter S. Tomenson Jr., Independent Director (Age 69)
  • Fred J. Weinert, Independent Director (Age 68)

Who owns Psychemedics stock?

Psychemedics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (8.46%), Moors & Cabot Inc. (6.80%), Tieton Capital Management LLC (5.21%), North Star Investment Management Corp. (1.48%), Acadian Asset Management LLC (1.37%) and Municipal Employees Retirement System of Michigan (1.07%). Company insiders that own Psychemedics stock include Fred J Weinert, Harry F Sr Connick Sr, James V Dyke, Michael I Schaffer, Neil Lerner and Raymond C Kubacki Jr. View Institutional Ownership Trends for Psychemedics.

Who sold Psychemedics stock? Who is selling Psychemedics stock?

Psychemedics' stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Renaissance Technologies LLC, Deutsche Bank AG, Alambic Investment Management L.P., Acadian Asset Management LLC and Spark Investment Management LLC. Company insiders that have sold Psychemedics company stock in the last year include James V Dyke and Michael I Schaffer. View Insider Buying and Selling for Psychemedics.

Who bought Psychemedics stock? Who is buying Psychemedics stock?

Psychemedics' stock was acquired by a variety of institutional investors in the last quarter, including Moors & Cabot Inc., Tieton Capital Management LLC, Bank of New York Mellon Corp, LPL Financial LLC, LSV Asset Management, Municipal Employees Retirement System of Michigan, Two Sigma Investments LP and Algert Global LLC. Company insiders that have bought Psychemedics stock in the last two years include Harry F Sr Connick Sr and Raymond C Kubacki Jr. View Insider Buying and Selling for Psychemedics.

How do I buy Psychemedics stock?

Shares of Psychemedics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Psychemedics' stock price today?

One share of Psychemedics stock can currently be purchased for approximately $21.14.

How big of a company is Psychemedics?

Psychemedics has a market capitalization of $114.75 million and generates $38.98 million in revenue each year. The company earns $6.67 million in net income (profit) each year or $1.11 on an earnings per share basis. Psychemedics employs 206 workers across the globe.

How can I contact Psychemedics?

Psychemedics' mailing address is 125 Nagog Park Ste 200, ACTON, MA 01720-3451, United States. The company can be reached via phone at +1-800-6288073.


MarketBeat Community Rating for Psychemedics (PMD)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Psychemedics (NASDAQ:PMD) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Psychemedics (NASDAQ:PMD) Earnings History and Estimates Chart

Earnings by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018        
10/24/2017Q3 2017$0.25$10.05 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.16$9.68 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.27$10.21 millionViewN/AView Earnings Details
2/6/2017Q4 2016$0.43$10.76 millionViewN/AView Earnings Details
10/26/2016Q3 2016$0.49$11.85 millionViewN/AView Earnings Details
7/26/2016Q2 2016$0.30$9.70 millionViewN/AView Earnings Details
2/10/2016Q4 2015$0.03$6.13 millionViewN/AView Earnings Details
10/28/2015Q3 2015$0.15$7.08 millionViewN/AView Earnings Details
7/28/2015Q2 2015$0.05$7.00 millionViewN/AView Earnings Details
4/27/2015Q1 2015$0.05$6.76 millionViewN/AView Earnings Details
2/10/2015Q414$0.08$0.13$6.80 millionViewN/AView Earnings Details
10/30/2014Q3 2014$0.17$7.70 millionViewN/AView Earnings Details
7/28/2014$0.03$0.16$7.69 millionViewN/AView Earnings Details
4/29/2014Q114$0.12$0.14$6.40 million$7.00 millionViewN/AView Earnings Details
2/10/2014Q4$0.16$6.48 millionViewN/AView Earnings Details
10/28/2013Q313$0.20$7.06 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.20$6.90 millionViewN/AView Earnings Details
5/7/2013Q1 2013$0.16$6.43 millionViewN/AView Earnings Details
2/25/2013Q4 2012$0.05$5.55 million$5.66 millionViewN/AView Earnings Details
11/5/2012Q3 2012$0.17ViewN/AView Earnings Details
8/7/2012Q2 2012$0.19ViewN/AView Earnings Details
5/8/2012Q1 2012$0.16ViewN/AView Earnings Details
2/23/2012Q4 2011$0.08ViewN/AView Earnings Details
11/3/2011Q3 2011$0.19$0.21ViewN/AView Earnings Details
8/10/2011Q2 2011$0.21ViewN/AView Earnings Details
5/5/2011Q1 2011$0.10$0.16ViewN/AView Earnings Details
3/2/2011Q4 2010$0.08ViewN/AView Earnings Details
11/4/2010Q3 2010$0.12$0.16ViewN/AView Earnings Details
8/10/2010Q2 2010$0.10$0.17ViewN/AView Earnings Details
5/11/2010Q1 2010$0.06$0.10ViewN/AView Earnings Details
2/23/2010Q4 2009$0.10ViewN/AView Earnings Details
11/3/2009Q3 2009$0.15ViewN/AView Earnings Details
8/4/2009Q2 2009$0.03ViewN/AView Earnings Details
5/7/2009Q1 2009$0.01ViewN/AView Earnings Details
2/18/2009Q4 2008$0.03ViewN/AView Earnings Details
11/3/2008Q3 2008$0.17ViewN/AView Earnings Details
7/28/2008Q2 2008$0.20ViewN/AView Earnings Details
4/30/2008Q1 2008$0.17ViewN/AView Earnings Details
2/14/2008Q4 2007$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Psychemedics (NASDAQ:PMD) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Psychemedics (NASDAQ:PMD) Dividend Information

Most Recent Dividend:11/17/2017
Annual Dividend:$0.60
Dividend Yield:2.84%
Payout Ratio:54.05% (Trailing 12 Months of Earnings)
Dividend Payments by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ:PMD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/25/2017quarterly$0.153.48%11/3/201711/6/201711/17/2017
8/3/2017quarterly$0.152.82%8/10/20178/14/20178/24/2017
4/26/2017quarterly$0.153.08%5/4/20175/8/20175/18/2017
2/6/2017Quarterly$0.152.89%2/14/20172/16/20172/27/2017
10/27/2016quarterly$0.152.62%11/3/201611/7/201611/17/2016
7/27/2016quarterly$0.153.29%8/3/20168/5/20168/15/2016
4/27/2016quarterly$0.154.15%5/4/20165/6/20165/18/2016
2/11/2016quarterly$0.155.75%2/18/20162/22/20163/4/2016
10/29/2015quarterly$0.156.01%11/5/201511/9/201511/19/2015
7/29/2015quarterly$0.155.12%8/5/20158/7/20158/18/2015
4/28/2015quarterly$0.153.71%5/6/20155/8/20155/18/2015
2/11/2015quarterly$0.153.97%2/19/20152/23/20153/6/2015
10/30/2014quarterly$0.154.17%11/6/201411/10/201411/20/2014
10/30/2014quarterly$0.1511/20/201411/10/2014
7/29/2014quarterly$0.154.22%8/5/20148/7/20148/18/2014
4/29/2014quarterly$0.153.81%5/7/20145/9/20145/19/2014
2/10/2014quarterly$0.153.8%2/19/20142/21/20143/7/2014
10/28/2013quarterly$0.154.28%11/6/201311/11/201311/22/2013
8/5/2013quarterly$0.154.68%8/13/20138/15/20138/28/2013
5/7/2013quarterly$0.155.34%5/15/20135/17/20135/30/2013
2/25/2013quarterly$0.154.98%3/5/20133/7/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Psychemedics (NASDAQ PMD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.60%
Institutional Ownership Percentage: 57.99%
Insider Trades by Quarter for Psychemedics (NASDAQ:PMD)
Institutional Ownership by Quarter for Psychemedics (NASDAQ:PMD)

Psychemedics (NASDAQ PMD) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2017Raymond C Kubacki JrCEOBuy1,000$16.88$16,880.00178,228View SEC Filing  
9/6/2017Michael I SchafferVPSell7,548$20.41$154,054.6841,273View SEC Filing  
9/5/2017Michael I SchafferVPSell4,400$20.37$89,628.0041,273View SEC Filing  
9/1/2017Michael I SchafferVPSell981$21.16$20,757.9641,273View SEC Filing  
3/9/2017James V DykeVPSell10,513$20.56$216,147.2817,050View SEC Filing  
12/14/2016James V DykeVPSell5,091$22.83$116,227.5331,024View SEC Filing  
12/9/2016Fred J WeinertDirectorSell4,601$24.45$112,494.4526,983View SEC Filing  
11/18/2016Neil LernerVPSell3,000$24.75$74,250.0025,722View SEC Filing  
11/15/2016James V DykeVPSell10,000$23.56$235,600.0037,654View SEC Filing  
3/2/2016Harry F Sr Connick SrDirectorBuy700$12.83$8,981.0041,362View SEC Filing  
2/26/2016Harry F Sr Connick SrDirectorBuy1,000$12.63$12,630.0040,262View SEC Filing  
2/24/2016Harry F Sr Connick SrDirectorBuy2,000$12.36$24,720.0038,262View SEC Filing  
2/22/2016Harry F Sr Connick SrDirectorBuy1,000$12.61$12,610.0038,262View SEC Filing  
2/19/2016Harry F Sr Connick SrDirectorBuy1,000$11.95$11,950.0037,662View SEC Filing  
2/16/2016Michael I SchafferVPBuy4,507$11.09$49,982.6346,472View SEC Filing  
12/2/2015David HodgeDirectorBuy550,000$0.01$5,500.00
11/24/2015David HodgeDirectorBuy260,000$0.01$2,600.00
9/14/2015Raymond C. Kubacki, Jr.CEOBuy2,000$10.12$20,240.00185,647View SEC Filing  
9/10/2015Neil LernerVPBuy3,000$10.32$30,960.0030,051View SEC Filing  
6/16/2015Michael I SchafferVPSell2,837$14.62$41,476.94View SEC Filing  
4/8/2015David HodgeDirectorBuy3,000$0.01$30.00
(Data available from 1/1/2013 forward)

Headlines

Psychemedics (NASDAQ PMD) News Headlines

Source:
DateHeadline
Psychemedics (PMD) to Release Earnings on MondayPsychemedics (PMD) to Release Earnings on Monday
www.americanbankingnews.com - January 29 at 3:56 AM
6 Cheap Stocks With a High Dividend Yield6 Cheap Stocks With a High Dividend Yield
finance.yahoo.com - January 3 at 4:46 PM
ETFs with exposure to Psychemedics Corp. : November 27, 2017ETFs with exposure to Psychemedics Corp. : November 27, 2017
finance.yahoo.com - November 27 at 4:33 PM
Psychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 SharesPsychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 Shares
www.americanbankingnews.com - November 15 at 10:20 AM
Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017
finance.yahoo.com - November 7 at 8:50 AM
Psychemedics Corporation (PMD) Rating Increased to Hold at BidaskClubPsychemedics Corporation (PMD) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - November 4 at 2:10 PM
ETFs with exposure to Psychemedics Corp. : October 30, 2017ETFs with exposure to Psychemedics Corp. : October 30, 2017
finance.yahoo.com - October 31 at 8:00 AM
Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
finance.yahoo.com - October 31 at 8:00 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 27 at 10:46 AM
Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15
www.americanbankingnews.com - October 26 at 9:01 AM
Psychemedics Corporation Announces Q3 EarningsPsychemedics Corporation Announces Q3 Earnings
finance.yahoo.com - October 25 at 9:14 AM
Psychemedics Corporation (PMD) Announces  Earnings ResultsPsychemedics Corporation (PMD) Announces Earnings Results
www.americanbankingnews.com - October 24 at 8:28 PM
Psychemedics Corporation (PMD) Set to Announce Quarterly Earnings on TuesdayPsychemedics Corporation (PMD) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 5:58 AM
Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM
Psychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM
Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair TestPsychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM
Insider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of StockInsider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM
Michael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM
Michael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) StockMichael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM
ETFs with exposure to Psychemedics Corp. : August 21, 2017ETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM
Psychemedics Corporation Launches Synthetic Cannabinoids Hair TestPsychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM
Psychemedics Corporation - First Lab Approved For Hair Testing In IowaPsychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM
Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM
Psychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly DividendPsychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM
Psychemedics Corporation Announces Q2 EarningsPsychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics posts 2Q profitPsychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM
Psychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on MondayPsychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM
Psychemedics posts 1Q profitPsychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM
Psychemedics Corp: Its Not A ShortPsychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM
The Royce Funds: An Analysis Of Particularly Interesting HoldingsThe Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff DeadlineSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The FirmDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM
PSYCHEMEDICS CORP Files SEC form 10-K, Annual ReportPSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM
PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMDSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMD
feeds.benzinga.com - February 17 at 9:51 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics CorporationINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation
feeds.benzinga.com - February 17 at 11:12 AM
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the FirmGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 15 at 4:36 AM
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action LawsuitINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 15 at 4:36 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMDSHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD
us.rd.yahoo.com - February 13 at 11:23 PM
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the FirmEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMDSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMD
us.rd.yahoo.com - February 11 at 1:33 AM
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff DeadlineSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - February 7 at 2:55 PM

SEC Filings

Psychemedics (NASDAQ:PMD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Psychemedics (NASDAQ:PMD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Psychemedics (NASDAQ PMD) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.